<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://www.w3.org/2005/Atom">
<title>Department of Pediatrics</title>
<link href="http://hdl.handle.net/2144/956" rel="alternate"/>
<subtitle>Pediatrics</subtitle>
<id>http://hdl.handle.net/2144/956</id>
<updated>2013-05-19T20:53:33Z</updated>
<dc:date>2013-05-19T20:53:33Z</dc:date>
<entry>
<title>Pelvic Inflammatory Disease during the Post-Partum Year</title>
<link href="http://hdl.handle.net/2144/3264" rel="alternate"/>
<author>
<name>Mahon, Barbara E</name>
</author>
<author>
<name>Temkit, M'hamed</name>
</author>
<author>
<name>Wang, Jane</name>
</author>
<author>
<name>Rosenman, Marc B</name>
</author>
<author>
<name>Katz, Barry P</name>
</author>
<id>http://hdl.handle.net/2144/3264</id>
<updated>2012-01-12T07:01:22Z</updated>
<published>2005-01-01T00:00:00Z</published>
<summary type="text">Pelvic Inflammatory Disease during the Post-Partum Year
Mahon, Barbara E; Temkit, M'hamed; Wang, Jane; Rosenman, Marc B; Katz, Barry P
OBJECTIVE: To investigate the occurrence of, and risk factors for, pelvic inflammatory disease (PID) occurring during the post-partum year. METHODS: Demographic and clinical data for women who delivered a term infant with 5-minute Apgar score &gt; or = 8 from 1992 through 1999 at a large urban hospital were extracted from an electronic medical record system. RESULTS: During the study period, 15 206 deliveries occurred among 12 549 women. PID was diagnosed during the post-partum year of 148 (1.0%) deliveries. In univariate analysis, young age, black race, and both pre-delivery history and post-partum diagnosis of chlamydial and gonococcal infection were associated with PID. In multivariate analysis, only young age and a positive test for gonorrhea before delivery or post-partum were independent predictors of PID. CONCLUSIONS: Pelvic inflammatory disease was diagnosed during the post-partum year in 1% of women studied. Young maternal age was an important demographic risk factor. Further investigation of post-partum STD acquisition and progression to PID is needed to determine whether women are at increased risk following delivery.
</summary>
<dc:date>2005-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Implications for Registry-Based Vaccine Effectiveness Studies from an Evaluation of an Immunization Registry: A Cross-Sectional Study</title>
<link href="http://hdl.handle.net/2144/3260" rel="alternate"/>
<author>
<name>Mahon, Barbara E</name>
</author>
<author>
<name>Shea, Kimberly M</name>
</author>
<author>
<name>Dougherty, Nancy N</name>
</author>
<author>
<name>Loughlin, Anita M</name>
</author>
<id>http://hdl.handle.net/2144/3260</id>
<updated>2012-01-12T07:01:20Z</updated>
<published>2008-05-14T00:00:00Z</published>
<summary type="text">Implications for Registry-Based Vaccine Effectiveness Studies from an Evaluation of an Immunization Registry: A Cross-Sectional Study
Mahon, Barbara E; Shea, Kimberly M; Dougherty, Nancy N; Loughlin, Anita M
BACKGROUND. Population-based electronic immunization registries create the possibility of using registry data to conduct vaccine effectiveness studies which could have methodological advantages over traditional observational studies. For study validity, the base population would have to be clearly defined and the immunization status of members of the population accurately recorded in the registry. We evaluated a city-wide immunization registry, focusing on its potential as a tool to study pertussis vaccine effectiveness, especially in adolescents. METHODS. We conducted two evaluations – one in sites that were active registry participants and one in sites that had implemented an electronic medical record with plans for future direct data transfer to the registry – of the ability to match patients' medical records to registry records and the accuracy of immunization records in the registry. For each site, records from current pediatric patients were chosen randomly. Data regarding pertussis-related immunizations, clinic usage, and demographic and identifying information were recorded; for 11–17-year-old subjects, information on MMR, hepatitis B, and varicella immunizations was also collected. Records were then matched, when possible, to registry records. For records with a registry match, immunization data were compared. RESULTS. Among 350 subjects from sites that were current registry users, 307 (87.7%) matched a registry record. Discrepancies in pertussis-related data were common for up-to-date status (22.6%), number of immunizations (34.7%), dates (10.2%), and formulation (34.4%). Among 442 subjects from sites that planned direct electronic transfer of immunization data to the registry, 393 (88.9%) would have matched a registry record; discrepancies occurred frequently in number of immunizations (11.9%), formulation (29.1%), manufacturer (94.4%), and lot number (95.1%.) Inability to match and immunization discrepancies were both more common in subjects who were older at their first visit to the provider site. For 11–17-year-old subjects, discrepancies were also common for MMR, hepatitis B, and varicella vaccination data. CONCLUSION. Provider records frequently could not be matched to registry records or had discrepancies in key immunization data. These issues were more common for older children and were present even with electronic data transfer. These results highlight general challenges that may face investigators wishing to use registry-based immunization data for vaccine effectiveness studies, especially in adolescents.
</summary>
<dc:date>2008-05-14T00:00:00Z</dc:date>
</entry>
<entry>
<title>An Obesity Dietary Quality Index Predicts Abdominal Obesity in Women: Potential Opportunity for New Prevention and Treatment Paradigms</title>
<link href="http://hdl.handle.net/2144/3149" rel="alternate"/>
<author>
<name>Wolongevicz, Dolores M.</name>
</author>
<author>
<name>Zhu, Lei</name>
</author>
<author>
<name>Pencina, Michael J.</name>
</author>
<author>
<name>Kimokoti, Ruth W.</name>
</author>
<author>
<name>Newby, P. K.</name>
</author>
<author>
<name>D'Agostino, Ralph B.</name>
</author>
<author>
<name>Millen, Barbara E.</name>
</author>
<id>http://hdl.handle.net/2144/3149</id>
<updated>2012-01-12T07:00:32Z</updated>
<published>2010-01-05T00:00:00Z</published>
<summary type="text">An Obesity Dietary Quality Index Predicts Abdominal Obesity in Women: Potential Opportunity for New Prevention and Treatment Paradigms
Wolongevicz, Dolores M.; Zhu, Lei; Pencina, Michael J.; Kimokoti, Ruth W.; Newby, P. K.; D'Agostino, Ralph B.; Millen, Barbara E.
Background. Links between dietary quality and abdominal obesity are poorly understood. Objective. To examine the association between an obesity-specific dietary quality index and abdominal obesity risk in women. 

Methods. Over 12 years, we followed 288 Framingham Offspring/Spouse Study women, aged 30–69 years, without metabolic syndrome risk factors, cardiovascular disease, cancer, or diabetes at baseline. An 11-nutrient obesity-specific dietary quality index was derived using mean ranks of nutrient intakes from 3-day dietary records. Abdominal obesity (waist circumference &gt;88cm) was assessed during follow-up. 

Results. Using multiple logistic regression, women with poorer dietary quality were more likely to develop abdominal obesity compared to those with higher dietary quality (OR 1.87; 95% CI, 1.01, 3.47; P for trend = .048) independent of age, physical activity, smoking, and menopausal status.

Conclusions. An obesity-specific dietary quality index predicted abdominal obesity in women, suggesting targets for dietary quality assessment, intervention, and treatment to address abdominal adiposity.
</summary>
<dc:date>2010-01-05T00:00:00Z</dc:date>
</entry>
<entry>
<title>Community Case Management of Fever Due to Malaria and Pneumonia in Children Under Five in Zambia: A Cluster Randomized Controlled Trial</title>
<link href="http://hdl.handle.net/2144/2965" rel="alternate"/>
<author>
<name>Yeboah-Antwi, Kojo</name>
</author>
<author>
<name>Pilingana, Portipher</name>
</author>
<author>
<name>Macleod, William B.</name>
</author>
<author>
<name>Semrau, Katherine</name>
</author>
<author>
<name>Siazeele, Kazungu</name>
</author>
<author>
<name>Kalesha, Penelope</name>
</author>
<author>
<name>Hamainza, Busiku</name>
</author>
<author>
<name>Seidenberg, Phil</name>
</author>
<author>
<name>Mazimba, Arthur</name>
</author>
<author>
<name>Sabin, Lora</name>
</author>
<author>
<name>Kamholz, Karen</name>
</author>
<author>
<name>Thea, Donald M.</name>
</author>
<author>
<name>Hamer, Davidson H.</name>
</author>
<id>http://hdl.handle.net/2144/2965</id>
<updated>2012-01-10T07:01:24Z</updated>
<published>2010-09-21T00:00:00Z</published>
<summary type="text">Community Case Management of Fever Due to Malaria and Pneumonia in Children Under Five in Zambia: A Cluster Randomized Controlled Trial
Yeboah-Antwi, Kojo; Pilingana, Portipher; Macleod, William B.; Semrau, Katherine; Siazeele, Kazungu; Kalesha, Penelope; Hamainza, Busiku; Seidenberg, Phil; Mazimba, Arthur; Sabin, Lora; Kamholz, Karen; Thea, Donald M.; Hamer, Davidson H.
In a cluster randomized trial, Kojo Yeboah-Antwi and colleagues find that integrated management of malaria and pneumonia in children under five by community health workers is both feasible and effective. 

BACKGROUND. 

Pneumonia and malaria, two of the leading causes of morbidity and mortality among children under five in Zambia, often have overlapping clinical manifestations. Zambia is piloting the use of artemether-lumefantrine (AL) by community health workers (CHWs) to treat uncomplicated malaria. Valid concerns about potential overuse of AL could be addressed by the use of malaria rapid diagnostics employed at the community level. Currently, CHWs in Zambia evaluate and treat children with suspected malaria in rural areas, but they refer children with suspected pneumonia to the nearest health facility. This study was designed to assess the effectiveness and feasibility of using CHWs to manage nonsevere pneumonia and uncomplicated malaria with the aid of rapid diagnostic tests (RDTs). 

METHODS AND FINDINGS. 

Community health posts staffed by CHWs were matched and randomly allocated to intervention and control arms. Children between the ages of 6 months and 5 years were managed according to the study protocol, as follows. Intervention CHWs performed RDTs, treated test-positive children with AL, and treated those with nonsevere pneumonia (increased respiratory rate) with amoxicillin. Control CHWs did not perform RDTs, treated all febrile children with AL, and referred those with signs of pneumonia to the health facility, as per Ministry of Health policy. The primary outcomes were the use of AL in children with fever and early and appropriate treatment with antibiotics for nonsevere pneumonia. A total of 3,125 children with fever and/or difficult/fast breathing were managed over a 12-month period. In the intervention arm, 27.5% (265/963) of children with fever received AL compared to 99.1% (2066/2084) of control children (risk ratio 0.23, 95% confidence interval 0.14–0.38). For children classified with nonsevere pneumonia, 68.2% (247/362) in the intervention arm and 13.3% (22/203) in the control arm received early and appropriate treatment (risk ratio 5.32, 95% confidence interval 2.19–8.94). There were two deaths in the intervention and one in the control arm. 

CONCLUSIONS.

The potential for CHWs to use RDTs, AL, and amoxicillin to manage both malaria and pneumonia at the community level is promising and might reduce overuse of AL, as well as provide early and appropriate treatment to children with nonsevere pneumonia.
</summary>
<dc:date>2010-09-21T00:00:00Z</dc:date>
</entry>
</feed>
